Dabrafenib trials for Melanoma

All Dabrafenib trials · All Melanoma trials

Phase breakdown

Recruiting trials studying Dabrafenib for Melanoma

• DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.
  NCT07440290 · Phase: Phase 2, Phase 3 · Ages: 1 Year and older · Sex: All (male and female) · 27 locations
• Dabrafenib and/or Trametinib Rollover Study
  NCT03340506 · Phase: Phase 4 · Ages: 18 Years to 100 Years · Sex: All (male and female) · 33 locations
• Melanoma Metastasized to the Brain and Steroids
  NCT03563729 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma
  NCT04903119 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 4 locations

Common questions

How many trials study Dabrafenib for Melanoma?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.